全球低劑量腸外藥物市場按配方、劑型、包裝類型、適應症、最終用戶和地區分類

Global Small Volume Parenteral Market, By Form, By Dose Type, By Packaging Type, By Indication Type, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球低容量腸外藥物市場規模估計為 2,075.7 億美元，預計到 2032 年將達到 3,443.7 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	2075.7億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	7.50%	2032年價值預測	3443.7億美元

低容量腸外給藥市場包括以小劑量（通常少於 100 毫升）給藥的腸外給藥藥物和製劑。低容量腸外給藥廣泛應用於糖尿病、癌症、感染疾病、鬱血性心臟衰竭疾病的治療。藥物可以透過靜脈注射、肌肉、皮下和皮內給藥等途徑直接進入血液。由於全球慢性和急性疾病的流行，低容量腸外給藥市場正在穩步成長。此外，老年人口的成長（他們容易出現多種健康問題）推動了對易於小劑量給藥的藥物的需求。然而，對腸外給藥藥物生產的嚴格規定和與市場發展相關的高成本可能會在一定程度上阻礙市場擴張。

市場動態：

全球低劑量腸外藥物市場主要受糖尿病、心血管疾病、癌症和呼吸系統疾病等慢性病盛行率上升的推動。根據世界衛生組織 (WHO) 估計，到 2020 年，慢性病將佔全球死亡人數的 70% 以上。此外，老年人口不斷成長，容易出現多種健康問題，這也推動了對低劑量腸外藥物的需求，以治療複雜的病症。此外，精準劑量、藥物即時輸送和繞過胃腸道吸收等優勢正在推動低劑量腸外藥物的應用。然而，腸外藥物開發的高成本和注射藥物生產的嚴格法律規範繼續限制市場成長。同時，新型藥物輸送系統的進步有望為相關人員創造有利可圖的機會。

本研究的主要特點

本報告對全球低容量腸外藥物市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025-2032 的市場規模和年複合成長率(CAGR)。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球小容量腸外藥物市場的主要企業已根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數進行了分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球低劑量腸外藥物市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球小容量腸外藥物市場的各種策略矩陣來做出決策。

Fresenius Kabi AG
- 公司簡介
- 產品/服務組合
- 財務表現
- 最新動態/更新
Strategic Overview
Baxter
Sichuan Kelun
BML Parenteral Drugs
ICU Medical, Inc.
Pfizer Inc.
Becton Dickinson and Company
B. Braun Melsungen AG
WuXi AppTec
Akums Drugs &Pharmaceuticals Ltd.
Orion Corporation
Rusoma Laboratories Private Limited
Higgs Healthcare
Syntegon Technology GmbH

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI6522

Global Small Volume Parenteral Market is estimated to be valued at USD 207.57 Bn in 2025 and is expected to reach USD 344.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 207.57 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.50%	2032 Value Projection:	USD 344.37 Bn

The small volume parenteral market consists of parenteral drugs and formulations administered in small volumes usually less than 100 milliliter. Small volume parenteral find widespread application in treating conditions such as diabetes, cancer, infections, and congestive heart failures. They aid in delivering medications directly into the bloodstream through routes such as intravenous, intramuscular, subcutaneous, and intradermal delivery. The small volume parenteral formulations market has been witnessing steady growth driven by the growing prevalence of chronic and acute diseases worldwide. Moreover, the rising geriatric population prone to multiple health conditions has boosted the demand for easily administrable drugs in mini doses. However, stringent regulations for manufacturing parenteral drugs and high costs that are associated with drug development may impede the market expansion to some extent.

Market Dynamics:

Global small volume parenteral market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory diseases. As per the estimates of World Health Organization (WHO), chronic diseases accounted for over 70% of all deaths worldwide in 2020. Growing geriatric population base which is also susceptible to multiple health issues, has intensified the demand for small volume parenteral formulations to manage complex conditions. Furthermore, advantages such as precise dosing, immediate delivery of medication, and bypassing gastrointestinal absorption have augmented the adoption of small volume parenteral. However, high costs associated with parenteral drug development and stringent regulatory framework for manufacturing injectable drugs continues to restrict the market growth. On the other hand, ongoing advancements in novel drug delivery systems are expected to unleash lucrative opportunities for stakeholders.

Key features of the study:

This report provides in-depth analysis of the global small volume parenteral market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global small volume parenteral market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Kabi AG, Baxter, Sichuan Kelun, BML Parenteral Drugs, ICU Medical, Inc., Pfizer Inc., Becton Dickinson and Company, B. Braun Melsungen AG, WuXi AppTec , Akums Drugs & Pharmaceuticals Ltd., Orion Corporation, Rusoma Laboratories Private Limited, Higgs Healthcare and Syntegon Technology GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global small volume parenteral market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small volume parenteral market

Detailed Segmentation:

Global Small Volume Parenteral Market, By Form
- Liquid
- Dry
Global Small Volume Parenteral Market, By Dosage Type
- Single-dose
- Multiple-dose
Global Small Volume Parenteral Market, By Packaging Type
- Ampoules
- Vials
- Pre-filled Syringes
- Cartridges
- Bottles
- Others
Global Small Volume Parenteral Market, By Indication Type
- Pain Management
- Cancer Care
- Malnourishment
- Gastrointestinal disorder/Diarrhea
- Diabetes
- Others
Global Small Volume Parenteral Market, By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Global Small Volume Parenteral Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Fresenius Kabi AG
- Baxter
- Sichuan Kelun
- BML Parenteral Drugs
- ICU Medical, Inc.
- Pfizer Inc.
- Becton Dickinson and Company
- Braun Melsungen AG
- WuXi AppTec
- Akums Drugs & Pharmaceuticals Ltd.
- Orion Corporation
- Rusoma Laboratories Private Limited
- Higgs Healthcare
- Syntegon Technology GmbH

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Top 3 Market Findings
- Top 3 Market Opportunity

3. Key Industry Insights

Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals/Launches
Company Market Share Analysis

4. Small Volume Parenteral Market, By Form, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
Liquid, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Dry, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

5. Small Volume Parenteral Market, By Dose Type, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Single-dose, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Multiple-dose, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

6. Small Volume Parenteral Market, By Packaging Type, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
Ampoules, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Vials, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Pre-filled Syringes, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Cartridges, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Bottles, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Others, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

7. Small Volume Parenteral Market, By Indication Type, 2020 - 2032 ( US$ Billion)

Introduction
- Market Share Analysis, 2020 - 2032, ( US$ Billion)
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Cancer Care, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Malnourishment, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Gastrointestinal Disorder/diarrhea, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Diabetes, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
Others, 2020 - 2032( US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)

8. Small Volume Parenteral Market, By End User, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
Hospitals, 2020 - 2032( US$ Billion)
Clinics, 2020 - 2032( US$ Billion)
Ambulatory Surgical Centers, 2020 - 2032( US$ Billion)
Others, 2020 - 2032( US$ Billion)

9. Small Volume Parenteral Market, By Region, 2020 - 2032 ( US$ Billion)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
- Segment Trends
By Region
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Billion)
North America
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest Of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - GCC
  - Israel
  - Rest Of Middle East
Latin America
- Introduction
- Market Size and Forecast, By Form, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Dose Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Indication Type, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By End User, 2020 - 2032, ( US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Billion)
  - Brazil
  - Mexico
  - Argentina

10. Company Profiles - Small Volume Parenteral Market

Fresenius Kabi AG
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
Strategic Overview
Baxter
Sichuan Kelun
BML Parenteral Drugs
ICU Medical, Inc.
Pfizer Inc.
Becton Dickinson and Company
B. Braun Melsungen AG
WuXi AppTec
Akums Drugs & Pharmaceuticals Ltd.
Orion Corporation
Rusoma Laboratories Private Limited
Higgs Healthcare
Syntegon Technology GmbH